Ratings Bodal Chemicals Limited

Equities

Market Closed - Bombay S.E. Other stock markets 03:30:50 13/05/2024 pm IST			5-day change	1st Jan Change
72.06 ^INR	-0.68%		-5.22%	-12.99%

06/03	Bodal Chemicals Limited announced that it expects to receive INR 214 million in funding	CI
13/02	Transcript : Bodal Chemicals Limited, Q3 2024 Earnings Call, Feb 13, 2024

Overall, the company has poor fundamentals for a medium to long-term investment strategy.

Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Analyst opinion has improved significantly over the past four months.
Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
The group usually releases upbeat results with huge surprise rates.

The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
The company sustains low margins.
The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 120.92 times its estimated earnings per share for the ongoing year.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Over the past twelve months, analysts' opinions have been revised negatively.

	1st Jan change	Capi.	ESG Refinitiv
BODAL CHEMICALS LIMITED	-12.99%	109M	-
ECOLAB INC.	+17.73%	66.69B	A-
GIVAUDAN SA	+17.54%	41.24B	B+
FUJIFILM HOLDINGS CORPORATION	+20.17%	25.89B	A-
EMS-CHEMIE HOLDING AG	+11.89%	19.81B	C+
CELANESE CORPORATION	+0.85%	17.11B	B+
POSCO FUTURE M CO., LTD.	-21.87%	15.86B	A-
SYMRISE AG	+2.57%	15.35B	B+
ALBEMARLE CORPORATION	-10.29%	15.23B	C+
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.	-22.30%	13.36B	A-

Investor Rating

Trading Rating

ESG Refinitiv

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality